Alcon Vision, LLC

Alcon Vision, LLC (doing business as Alcon), a subsidiary of Alcon Laboratories, Inc., supplies ophthalmic surgical equipment, intraocular lenses, pharmaceutical eye products, surgical consumables, and maintenance and repair services to federal healthcare agencies as a large-business prime contractor with no set-aside designation.

Alcon competes exclusively in full-and-open federal procurements across the Department of Veterans Affairs, Defense Health Agency, Department of Defense military treatment facilities, and other federal healthcare networks. The company's concrete capability portfolio centers on cataract surgery systems (Centurion Vision and Constellation platforms), femtosecond and excimer laser surgical systems (LenSx, Alcon Lasers, and Constellation LXT), phacoemulsification equipment and consumables (phaco packs, cataract surgical kits), intraocular lenses in multiple designs (posterior chamber, anterior chamber, multifocal extended-vision), ophthalmic pharmaceutical solutions (tetracaine, naphazoline-pheniramine, betadine, systane products), and comprehensive equipment maintenance, repair, and calibration services. Recent representative work includes a $595.7 million firm fixed-price purchase order from Veterans Integrated Service Network 1 (awarded October 2024) for laser service and maintenance through September 2028; a $63.8 million single-award indefinite delivery contract from the Department of Veterans Affairs (awarded January 2024, expiring January 2027) for next-generation surgical implant devices; a $2.1 billion single-award indefinite delivery contract from VA Veterans Integrated Service Network 12 (awarded January 2024) for intraocular lenses and associated surgical supplies; and a $1.25 million blanket purchase agreement from the Defense Health Agency (awarded June 2025) for surgical optical supplies and implants through May 2030.

Customer concentration is driven heavily by VA network-specific awards. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 anchors 93% of combined potential value across the recent award portfolio (15 awards, $1.84 billion), while the Defense Health Agency places the highest award count among defense customers (128 awards, $29.2 million combined potential value) but significantly smaller transaction sizes. The Defense Logistics Agency Troop Support Medical dominates award volume by count (181 awards, $3.8 million combined potential value), reflecting high-velocity, small-dollar pharmaceutical and consumables delivery orders. The top five customers by either metric account for 66% of all awards and 93% of combined potential value, with tension between award count (DLA and DHA lead) and dollar concentration (VA VISN 12 dominates).

Alcon's federal vehicle posture centers on indefinite delivery contracts and blanket purchase agreements established directly with specific VA networks and the Defense Health Agency, rather than government-wide acquisition contracts or GSA schedules. The company holds position on the GSA Medical Equipment and Supplies Schedule (FSS-65-II-A), through which task orders are issued for intraocular lenses and surgical optical supplies; 35 task orders under the Medical Equipment and Supplies vehicle carry $7.5 million combined potential value. Two large single-award IDIQ vehicles dominate the task-order pipeline: a VA indefinite delivery contract (SPE2D021D0001) with 180 task orders and $347 thousand combined potential value, and another VA IDIQ (36C10G18D0110) with 19 task orders and $2.7 million combined potential value. Navy and Army medical command blanket purchase agreements (N0025921A0006 and N0025921A0005) carry 15 and 13 task orders respectively in the low thousands of dollars per order.

Activity has grown substantially: 88 awards in 2022, declining to 45 in 2024, then recovering to 51 in 2025 and 119 in 2026 (year-to-date through late September). The recent surge reflects a combination of seasonal government purchasing patterns and increased exercise of option years on large service contracts. Twenty-seven awards with ultimate completion dates within the next twenty-four months carry combined potential value of $4 million and therefore face recompete exposure — a modest recompete cliff relative to Alcon's total portfolio, suggesting contract continuity rather than cliff-driven risk.

Alcon operates as a pure prime contractor across all recent federal work; the source identifies zero subcontract activity. The company manufactures and performs service delivery from its Fort Worth, Texas headquarters, with place of performance specified at Fort Worth for manufacturing and shipping, though maintenance, repair, and calibration services are delivered onsite at customer facilities nationwide (VA medical centers, military treatment facilities, Indian Health Service locations). The vendor performs under sole-source procurement authority in approximately one-third of awards, justified under FAR 6.302-1 and FAR 13.106-1(b) as the original equipment manufacturer of proprietary surgical systems and the only source capable of providing factory-authorized maintenance and replacement parts without unacceptable delays or cost duplication.

Alcon Laboratories, Inc. is the parent entity; Alcon Vision, LLC is the operating subsidiary through which all federal contracting flows. The source does not disclose ownership structure beyond the parent-subsidiary relationship or any other corporate affiliates relevant to federal contracting.